Agnès Bénardeau

1.9k total citations
43 papers, 1.4k citations indexed

About

Agnès Bénardeau is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Agnès Bénardeau has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Cardiology and Cardiovascular Medicine and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Agnès Bénardeau's work include Cardiac electrophysiology and arrhythmias (10 papers), Pancreatic function and diabetes (8 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Agnès Bénardeau is often cited by papers focused on Cardiac electrophysiology and arrhythmias (10 papers), Pancreatic function and diabetes (8 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Agnès Bénardeau collaborates with scholars based in Switzerland, Germany and Denmark. Agnès Bénardeau's co-authors include Stéphane Hatem, Stanley Nattel, J.-J. Mercadier, Rodolphe Fischmeister, M. Rivet-Bastide, Bernard Thibault, Samir Fareh, Danshi Li, Michael Kirstein and Catherine Rücker‐Martin and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Circulation Research.

In The Last Decade

Agnès Bénardeau

40 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Agnès Bénardeau Switzerland	23	750	657	236	187	174	43	1.4k
Yoshiko Tokutomi Japan	21	487 0.6×	488 0.7×	392 1.7×	75 0.4×	273 1.6×	34	1.6k
Yi‐Fei Dong Japan	20	320 0.4×	494 0.8×	281 1.2×	64 0.3×	274 1.6×	27	1.2k
María Antonia Fortuño Spain	24	700 0.9×	841 1.3×	550 2.3×	80 0.4×	320 1.8×	36	2.0k
Angelo J. Trapani United States	23	525 0.7×	661 1.0×	448 1.9×	209 1.1×	325 1.9×	74	1.6k
Anthony J. Balmforth United Kingdom	22	783 1.0×	683 1.0×	189 0.8×	264 1.4×	356 2.0×	59	1.7k
Rachel Laskey United States	24	517 0.7×	541 0.8×	442 1.9×	184 1.0×	318 1.8×	41	1.7k
Andrea A. Seymour United States	24	415 0.6×	839 1.3×	174 0.7×	247 1.3×	296 1.7×	60	1.4k
Akiko Ogai Japan	22	963 1.3×	807 1.2×	315 1.3×	107 0.6×	221 1.3×	33	2.4k
Hiroaki Shirahase Japan	19	425 0.6×	223 0.3×	446 1.9×	191 1.0×	102 0.6×	97	1.1k
Christopher Ho United States	8	488 0.7×	452 0.7×	294 1.2×	41 0.2×	373 2.1×	8	1.2k

Countries citing papers authored by Agnès Bénardeau

Since Specialization

Citations

This map shows the geographic impact of Agnès Bénardeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnès Bénardeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnès Bénardeau more than expected).

Fields of papers citing papers by Agnès Bénardeau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnès Bénardeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnès Bénardeau. The network helps show where Agnès Bénardeau may publish in the future.

Co-authorship network of co-authors of Agnès Bénardeau

This figure shows the co-authorship network connecting the top 25 collaborators of Agnès Bénardeau. A scholar is included among the top collaborators of Agnès Bénardeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnès Bénardeau. Agnès Bénardeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kraehling, Jan R., Agnès Bénardeau, Tibor Schomber, et al.. (2023). The sGC Activator Runcaciguat Has Kidney Protective Effects and Prevents a Decline of Kidney Function in ZSF1 Rats. International Journal of Molecular Sciences. 24(17). 13226–13226. 7 indexed citations

Patel, Rohit, et al.. (2022). Responses in Blood Pressure and Kidney Function to Soluble Guanylyl Cyclase Stimulation or Activation in Normal and Diabetic Rats. The Nephron journals/Nephron journals. 147(5). 281–300.

Bénardeau, Agnès, Antje Kahnert, Tibor Schomber, et al.. (2021). Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney disease. Naunyn-Schmiedeberg s Archives of Pharmacology. 394(12). 2363–2379. 24 indexed citations

Bénardeau, Agnès, Shuya Liu, Shun Lu, et al.. (2021). Assessment of Candidate Renal Protective Drug-Induced Biomarkers in Diabetic Kidney Disease Using Targeted Proteomic Profiling. Journal of the American Society of Nephrology. 32(10S). 255–256.

Bénardeau, Agnès, Michael G. Hahn, Michael Gerisch, et al.. (2020). The Novel Soluble Guanylyl Cyclase (sGC) Activator Runcaciguat Induced Renal Vasodilation and Reduced Kidney Damage in a Rat CKD Model. Journal of the American Society of Nephrology. 31(10S). 232–232. 1 indexed citations

Zhao, Liang, Tibor Schomber, Stefan Gölz, et al.. (2020). Role of soluble guanylyl cyclase in renal afferent and efferent arterioles. American Journal of Physiology-Renal Physiology. 320(2). F193–F202. 9 indexed citations

Bénardeau, Agnès, Johannes‐Peter Stasch, Michael G. Hahn, et al.. (2020). The Novel Soluble Guanylyl Cyclase (sGC) Activator Runcaciguat Attenuates Hypertensive Cardiorenal Rat Diseases. Journal of the American Society of Nephrology. 31(10S). 244–244. 1 indexed citations

Zoja, Carla, Monica Locatelli, Daniela Corna, et al.. (2015). Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy. The Nephron journals/Nephron journals. 132(1). 59–69. 41 indexed citations

Rapp, W., S. Raab, William Riboulet, et al.. (2015). Semiautomated quantitative image analysis of glomerular immunohistochemistry markers desmin, vimentin, podocin, synaptopodin and WT-1 in acute and chronic rat kidney disease models. Histochemistry and Cell Biology. 145(3). 315–326. 32 indexed citations

10.

Bénardeau, Agnès, et al.. (2013). Animal models of metabolic syndrome and associated co-morbidities. 1(1). 152–155.

11.

Samadfam, Rana, Agnès Bénardeau, Frieder Bauss, et al.. (2011). Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats. Journal of Endocrinology. 212(2). 179–186. 12 indexed citations

12.

Hebeisen, Paul, Wolfgang Haap, Bernd Kuhn, et al.. (2011). Orally active aminopyridines as inhibitors of tetrameric fructose-1,6-bisphosphatase. Bioorganic & Medicinal Chemistry Letters. 21(11). 3237–3242. 14 indexed citations

13.

Hansen, Barbara C., Xenia T. Tigno, Agnès Bénardeau, et al.. (2011). Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome. Cardiovascular Diabetology. 10(1). 7–7. 36 indexed citations

14.

Clerc, Roger G., Anne Perez, Jean-Christophe Hoflack, et al.. (2010). Mechanisms underlying off-target effects of the cholesteryl ester transfer protein inhibitor torcetrapib involve L-type calcium channels. Journal of Hypertension. 28(8). 1676–1686. 46 indexed citations

15.

Uhles, Sabine, Agnès Bénardeau, Michael Prummer, et al.. (2010). Taspoglutide, a novel human once‐weekly GLP‐1 analogue, protects pancreatic β ‐cells in vitro and preserves islet structure and function in the Zucker diabetic fatty rat in vivo. Diabetes Obesity and Metabolism. 13(4). 326–336. 4 indexed citations

16.

Kastelein, John J.P., Agnès Bénardeau, Olaf Kuhlmann, et al.. (2009). Dalcetrapib: no off‐target toxicity on blood pressure or on genes related to the renin‐angiotensin‐aldosterone system in rats. British Journal of Pharmacology. 158(7). 1763–1770. 39 indexed citations

17.

Kitas, Eric, Peter J. Mohr, Bernd Kuhn, et al.. (2009). Sulfonylureido thiazoles as fructose-1,6-bisphosphatase inhibitors for the treatment of Type-2 diabetes. Bioorganic & Medicinal Chemistry Letters. 20(2). 594–599. 25 indexed citations

18.

Bénardeau, Agnès. (2001). Effects of verapamil on atrial fibrillation and its electrophysiological determinants in dogs. Cardiovascular Research. 50(1). 85–96. 31 indexed citations

19.

Hatem, Stéphane, Agnès Bénardeau, Catherine Rücker‐Martin, et al.. (1996). Differential regulation of voltage-activated potassium currents in cultured human atrial myocytes. American Journal of Physiology-Heart and Circulatory Physiology. 271(4). H1609–H1619. 12 indexed citations

20.

Kirstein, Michael, M. Rivet-Bastide, Stéphane Hatem, et al.. (1995). Nitric oxide regulates the calcium current in isolated human atrial myocytes.. Journal of Clinical Investigation. 95(2). 794–802. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact